-
Launch One Acquisition extends business combination deadline to Jan 15, 2027; ~$230M redeemed
Shareholders approved extension of combination period from July 15, 2026 to January 15, 2027.
-
Launch One Acquisition Corp. converts Class B shares, seeks extension to Jan 2027 via non-redemption agreements
Converted 5,749,999 Class B ordinary shares to Class A shares; now 28,749,999 Class A outstanding.
-
Launch One Acquisition postpones shareholder meeting to July 10 for extension vote
Meeting postponed from July 7 to July 10, 2026, to vote on extension of business combination deadline to Jan 15, 2027.
-
Launch One Acquisition terminates business combination with Minovia Therapeutics
Mutual termination effective Jan 30, 2026; BCA originally signed June 25, 2025 and amended four times.
-
Launch One SPAC to acquire Minovia Therapeutics in $180M de-SPAC merger
Total consideration $180M in Pubco shares, plus $57.5M earnout tied to stock price ≥$11.50 or phase 3 trial start.
-
Launch One Acquisition Corp. to combine with Minovia Therapeutics at $180M valuation, targeting Q4 2025 close
Minovia pre-money valuation of $180M; equity holders eligible for up to $57.5M earnout based on milestones.
-
Launch One Acquisition Corp. completes $230M IPO and $6M private placement
Sold 23M units at $10.00 each (including full over-allotment of 3M units) for gross proceeds of $230M.